SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sam who wrote (2999)5/20/2020 10:40:32 PM
From: Investor21 Recommendation

Recommended By
Stock Puppy

  Read Replies (2) of 22883
 
Here is a quote taken from the conclusion of a report prepared by the World Health Organization in 2017, before the recent popularity of the U.S. press and politicians to bash the use of HCQ for treating Covid-19.

"Despite hundreds of millions of doses administered in the treatment of malaria, there have been
no reports of sudden unexplained death associated with quinine, chloroquine or amodiaquine,
although each drug causes QT/QTc interval prolongation."

(reference page 36, Conclusions and Recommendations, of the WHO's paper entitled, "The cardiotoxicity of antimalarials.")

who.int

Best wishes,

I2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News